you are here: Home News Sharon Bio Medicine

Sharon Bio Medicine

Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y
Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y
Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y
Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y
Sharon Bio Medi Standalone December 2020 Net Sales at Rs 45.24 crore, up 15.15% Y-o-Y
Sharon Bio Medi Standalone March 2020 Net Sales at Rs 45.79 crore, up 14.12% Y-o-Y
Sharon Bio Medi Standalone March 2019 Net Sales at Rs 40.13 crore, up 14.54% Y-o-Y
Sharon Bio Medi Standalone September 2018 Net Sales at Rs 39.18 crore, up 25.53% Y-o-Y
Sharon Bio Medicine surges 18% after UK drug regulator clears Dehradun unit
Stocks in news: SBI, M&M, Sun Pharma, Wockhardt, TeamLease, PVR
Sharon Bio-Medicine gets USFDA nod for API plant in Taloja
Sharon Bio up 20% on USFDA approval for API plant in Maharashtra
Stocks in news: Grasim, AB Nuvo, SBI, Prime Focus, Sharon, Alkem
Top buzzing midcap stocks to trade on June 22
Sharon Bio locked at 20% upper circuit post board meeting
Stocks in news: ITC, Max Ventures, Future Cons, Tech Mah, BASF
Sharon Bio Medi consolidated Dec '15 sales at Rs 104.69 crore
Stocks in news: BoB, BPCL, IDBI, Future Retail, Dr Lal, Clariant
Sharon Bio Medicine to shut down UAE subsidiary, stock down 15%
Stocks in news: TCS, Sun Pharma, UltraTech, Godfrey, GMR, GVK
Stocks in news: RComm, Wipro, Union Bank, Sharon Bio, GIC Hsg
Sharon Bio up 6%, R&D dept clears surveillance inspection
Top buzzing midcap stocks to trade on December 11
Maruti, Sharon Bio, Havells, Titan likely to be in focus
Sharon zooms on USFDA inspection report for Dehradun plant

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Sharon Bio Medicine

Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y

Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y

Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y

Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y

Sharon Bio Medi Standalone December 2020 Net Sales at Rs 45.24 crore, up 15.15% Y-o-Y

Sharon Bio Medi Standalone March 2020 Net Sales at Rs 45.79 crore, up 14.12% Y-o-Y

Sharon Bio Medi Standalone March 2019 Net Sales at Rs 40.13 crore, up 14.54% Y-o-Y

Sharon Bio Medi Standalone September 2018 Net Sales at Rs 39.18 crore, up 25.53% Y-o-Y

Sharon Bio Medicine surges 18% after UK drug regulator clears Dehradun unit

Stocks in news: SBI, M&M, Sun Pharma, Wockhardt, TeamLease, PVR

Sharon Bio-Medicine gets USFDA nod for API plant in Taloja

Sharon Bio up 20% on USFDA approval for API plant in Maharashtra

Stocks in news: Grasim, AB Nuvo, SBI, Prime Focus, Sharon, Alkem

Top buzzing midcap stocks to trade on June 22

Sharon Bio locked at 20% upper circuit post board meeting

Stocks in news: ITC, Max Ventures, Future Cons, Tech Mah, BASF

Sharon Bio Medi consolidated Dec '15 sales at Rs 104.69 crore

Stocks in news: BoB, BPCL, IDBI, Future Retail, Dr Lal, Clariant

Sharon Bio Medicine to shut down UAE subsidiary, stock down 15%

Stocks in news: TCS, Sun Pharma, UltraTech, Godfrey, GMR, GVK

Stocks in news: RComm, Wipro, Union Bank, Sharon Bio, GIC Hsg

Sharon Bio up 6%, R&D dept clears surveillance inspection

Top buzzing midcap stocks to trade on December 11

Maruti, Sharon Bio, Havells, Titan likely to be in focus

Sharon zooms on USFDA inspection report for Dehradun plant